Alder BioPharma (ALDR) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts ALDR Hot Sheet
Join SI Premium – FREE
Alder BioPharma (NASDAQ: ALDR) reported Q3 EPS of ($0.70), $0.15 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
